Impact of fat, protein, and glycemic index on postprandial glucose control in type 1diabetes: Implications for intensive diabetes management in the continuous glucose monitoring era

Diabetes Care

Volumn 38, Issue 6, 2015, Pages 1008-1015

  Bell, Kirstine J ^a,b   Smart, Carmel E ^c,d   Steil, Garry M ^e,f   Brand Miller, Jennie C ^a   King, Bruce ^c,d   Wolpert, Howard A ^b,f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b JOSLIN DIABETES CENTER   (United States)

^c JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FAT; GLUCOSE; INSULIN; INSULIN GLULISINE; INSULIN LISPRO; PROTEIN; ANTIDIABETIC AGENT; FAT INTAKE; GLUCOSE BLOOD LEVEL; PROTEIN INTAKE;

ALGORITHM; ARTICLE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE ANALYSIS; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DECISION SUPPORT SYSTEM; FAT INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; POSTPRANDIAL STATE; STOMACH EMPTYING; SYSTEMATIC REVIEW; TEST MEAL; CROSSOVER PROCEDURE; DIABETES MELLITUS, TYPE 1; HYPERGLYCEMIA; INSULIN INFUSION; MEAL; METABOLISM; PHARMACOLOGY; PHYSIOLOGY; PROTEIN INTAKE;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIETARY FATS; DIETARY PROTEINS; GLYCEMIC INDEX; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MEALS; POSTPRANDIAL PERIOD;

EID: 84947604788     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0100     Document Type: Article

References (41)

1. American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In Standards of Medical Care in Diabetesd2015. Diabetes Care 2015;38(Suppl. 1):S41-S48.
2. American Diabetes Association. Foundations of care: education, nutrition, physical activity, smoking cessation, psychosocial care, and immunization. Sec. 4. In Standards of Medical Care in Diabetesd2015. Diabetes Care 2015;38(Suppl. 1):S20-S30.
3. Klonoff DC, Buckingham B, Christiansen JS, et al.; Endocrine Society. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96:2968-2979.
4. Elleri D, Allen JM, Harris J, et al. Absorption patterns of meals containing complex carbohydrates in type 1 diabetes. Diabetologia 2013;56: 1108-1117.
5. Garćia-Lopez JM, Gonzalez-Rodriguez M, Pazos-Couselo M, Gude F, Prieto-Tenreiro A, Casanueva F. Should the amounts of fat and protein be taken into consideration to calculate the lunch prandial insulin bolus? Results from a randomized crossover trial. Diabetes Technol Ther 2013;15:166-171.
6. Lafrance L, Rabasa-Lhoret R, Poisson D, Ducros F, Chiasson JL. Effects of different glycaemic index foods and dietary fibre intake on glycaemic control in type 1 diabetic patients on intensive insulin therapy. Diabet Med 1998;15: 972-978.
7. Lodefalk M, Aman J, Bang P. Effects of fat supplementation on glycaemic response and gastric emptying in adolescents with type 1 diabetes. Diabet Med 2008;25:1030-1035.
8. MacDonald K, Lowe JM, Barker D, Mensch M, Attia J. Effect of popular takeaway foods on blood glucose levels in type 1 diabetes mellitus patients on intensive insulin therapy. Int J Clin Pract 2009;63:189-194.
9. Mohammed NH, Wolever TMS. Effect of carbohydrate source on post-prandial blood glucose in subjects with type 1 diabetes treated with insulin lispro. Diabetes Res Clin Pract 2004;65:29-35.
10. Nansel TR, Gellar L, McGill A. Effect of varying glycemic index meals on blood glucose control assessed with continuous glucose monitoring in youth with type 1 diabetes on basalbolus insulin regimens. Diabetes Care 2008;31: 695-697.
11. Neu A, Behret F, Braun R, et al. Higher glucose concentrations following protein- And fat-rich meals - the Tuebingen Grill Study: a pilot study in adolescents with type 1 diabetes. Pediatr Diabetes 20 October 2014 [Epub ahead of print].
12. Parillo M, Annuzzi G, Rivellese AA, et al. Effects of meals with different glycaemic index on postprandial blood glucose response in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion. Diabet Med 2011;28:227-229.
13. Paterson MA, Smart CE, McElduff P, et al. Influence of pure protein on postprandial blood glucose levels in individuals with type 1 diabetes mellitus (Abstract). Diabetes 2014; 63:A15.
14. Ryan RL, King BR, Anderson DG, Attia JR, Collins CE, Smart CE. Influence of and optimal insulin therapy for a low-glycemic index meal in children with type 1 diabetes receiving intensive insulin therapy. Diabetes Care 2008;31:1485- 1490.
15. Smart CEM, Evans M, O'Connell SM, et al. Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive. Diabetes Care 2013;36:3897-3902.
16. Uthoff H, Lehmann R, Sprenger M, Wiesli P. Skipping meals or carbohydrate-free meals in order to determine basal insulin requirements in subjects with type 1 diabetes mellitus? Exp Clin Endocrinol Diabetes 2010;118: 325-327.
17. Winiger G, Keller U, Laager R, Girard J, Berger W. Protein content of the evening meal and nocturnal plasma glucose regulation in type-I diabetic subjects. Horm Res 1995;44: 101-104.
18. Wolever TMS, Mullan YM. Sugars and fat have different effects on postprandial glucose responses in normal and type 1 diabetic subjects. Nutr Metab Cardiovasc Dis 2011;21: 719-725.
19. Wolpert HA, Atakov-Castillo A, Smith SA, Steil GM. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care 2013;36:810-816.
20. Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97: 2859-2865.
21. Gormsen LC, Nielsen C, Jessen N, Jørgensen JO, Møller N. Time-course effects of physiological free fatty acid surges on insulin sensitivity in humans. Acta Physiol (Oxf) 2011;201: 349-356.
22. Bao J, Gilbertson HR, Gray R, et al. Improving the estimation of mealtime insulin dose in adults with type 1 diabetes: The Normal Insulin Demand for Dose Adjustment (NIDDA) study. Diabetes Care 2011;34:2146-2151.
23. Bell KJ, Gray R, Munns D, et al. Estimating insulin demand for protein-containing foods using the food insulin index. Eur J Clin Nutr 2014; 68:1055-1059.
24. Chase HP, Saib SZ, MacKenzie T, Hansen MM, Garg SK. Post-prandial glucose excursions following four methods of bolus insulin administration in subjectswith type 1 diabetes. Diabet Med 2002;19:317-321.
25. Cobry E, McFann K, Messer L, et al. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther 2010;12:173- 177.
26. De Palma A, Giani E, Iafusco D, et al. Lowering postprandial glycemia in children with type 1 diabetes after Italian pizza "margherita" (TyBoDi2 Study). Diabetes Technol Ther 2011; 13:483-487.
27. Jones SM, Quarry JL, Caldwell-McMillan M, Mauger DT, Gabbay RA. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system. Diabetes Technol Ther 2005;7: 233-240.
28. Kordonouri O, Hartmann R, Remus K, Blasig S, Sadeghian E, Danne T. Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy. Pediatr Diabetes 2012;13:540-544.
29. Lee SW, Cao M, Sajid S, et al. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged postprandial hyperglycaemia better than standard bolus in type 1 diabetes. Diabetes Nutr Metab 2004;17:211-216.
30. Lindholm-Olinder A, Runefors J, Smide B, Kernell A. Post-prandial glucose levels following three methods of insulin bolusing: a study in adolescent girls and in compliance with girlswithout diabetes. Pract Diabetes Int 2009;26: 110-115.
31. Lopez P, Smart C, Morbey C, McElduff P, Paterson M, King BR. Extended insulin boluses cannot control postprandial glycemia as well as a standard bolus in children and adults using insulin pump therapy. BMJ Open Diab Res Care 2014;2:e0000050.
32. O'Connell MA, Gilbertson HR, Donath SM, Cameron FJ. Optimizing postprandial glycemia in pediatric patientswith type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type. Diabetes Care 2008;31:1491-1495.
33. Pankowska E, Błazik M, Groele L. Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: The conclusion of a randomized study. Diabetes Technol Ther 2012;14:16-22.
34. Scaramuzza AE, Iafusco D, Santoro L, et al. Timing of bolus in children with type 1 diabetes using continuous subcutaneous insulin infusion (TiBoDi Study). Diabetes Technol Ther 2010;12: 149-152.
35. Pankowska E, Szypowska A, Lipka M, Szpotá nska M, Błazik M, Groele L. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes. Pediatr Diabetes 2009;10:298- 303.
36. Bell K, Gray R, Munns D, et al. Food Insulin Index (FII) vs. traditional carbohydrate counting for glycemic control in adults with type 1 diabetes: a 3-month pilot study (Abstract). Diabetes 2014;63(Suppl.):A189.
37. Smart CE, Ross K, Edge JA, King BR, McElduff P, Collins CE. Can children with Type 1 diabetes and their caregivers estimate the carbohydrate content of meals and snacks?DiabetMed 2010;27:348-353.
38. Bell K, Toschi E, Wolpert H, Steil GM. Use of model predicted bolus estimation to optimize insulin dosing strategies covering high fat meals (Abstract). Diabetes Technol Ther 2015;17:A-22.
39. Nuffer W, Trujillo JM, Ellis SL. Technosphere insulin (Afrezza): a new, inhaled prandial insulin. Ann Pharmacother 2015;49:99-106.
40. Dauber A, Corcia L, Safer J, Agus MS, Einis S, Steil GM. Closed-loop insulin therapy improves glycemic control in children aged, 7 years: a randomized controlled trial. Diabetes Care 2013;36:222-227.
41. Steil GM, Agus MS. Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? Crit Care 2009;13:129.